Catalán Santos, Ú., López de las Hazas Mingo, M. d. C., Piñol Felis, C., Rubió Piqué, L., Motilva Casado, M. J., Fernández Castillejo, S., & Solà, R. (2018). Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway.
Citação norma ChicagoCatalán Santos, Úrsula, María del Carmen López de las Hazas Mingo, Carme Piñol Felis, Laura Rubió Piqué, Mª José Motilva Casado, Sara Fernández Castillejo, y Rosa Solà. Hydroxytyrosol and Its Main Plasma Circulating Metabolites Attenuate the Initial Steps of Atherosclerosis Through Inhibition of the MAPK Pathway. 2018.
Citação norma MLACatalán Santos, Úrsula, et al. Hydroxytyrosol and Its Main Plasma Circulating Metabolites Attenuate the Initial Steps of Atherosclerosis Through Inhibition of the MAPK Pathway. 2018.